Search Results for: Cipla

Karnataka sets 24-hr deadline for Cipla, Jubilant to supply Remdesivir

Karnataka has issued a show-cause notice to both the pharma majors for failing to supply the committed quantities of Remdesivir within the stipulated time frame

May 12, 2021

Gilead's Remdesivir authorised for emergency use only

Cipla Doubles Remdesivir Production In India For "Unprecedented" Demand

India's Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet "unprecedented demand" as the country battles a massive second wave of infections, the drugmaker said on Tuesday

Apr 13, 2021

Nifty, Sensex hit record highs as Biden win boosts IT stocks, Asian markets

Indian markets touched record highs on Monday as IT stocks gained after a report said that U.S. President-elect Joe Biden planned to ease policy on work visas, with his victory also boosting broader Asian markets and aiding domestic sentiment.

Nov 9, 2020

Zydus Cadila launches India's cheapest remdesivir version at $37 per vial

Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences' antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in the world's third-worst hit nation.

Aug 13, 2020

COVID-19 drug Favipiravir launched at ₹35 per tablet, cheapest available option

Favipiravir is an oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease.

Aug 5, 2020

India's Hetero wins approval to sell COVID drug favipiravir

India's Hetero Labs Ltd has received regulatory approval to sell its version of anti-viral drug favipiravir to treat COVID-19, the drugmaker said on Wednesday, as coronavirus infections in the world's third worst-hit nation crossed 1.5 million.

Jul 29, 2020

India sees record 49,000 new coronavirus cases, drug shortages in places

As the number of cases neared 1.3 million in India, local authorities scrambled to procure generic versions of remdesivir, the drug that has shown promise in clinical trials in treating severely-ill patients with COVID-19, the disease caused by the coronavirus.

Jul 24, 2020

High-priced Covid-19 drug Remdesivir being misused by hospitals across India

The Department of Pharmaceuticals has received several complaints regarding the "indiscriminate use" of Remdesivir by hospitals and it has raised the issue with the Ministry of Health and Family Welfare.

Jul 24, 2020

bse sensex, nse nifty, 2017 closing, brexit, demonetisation, modi, donald trump

Sensex, Nifty gain as HDFC Bank adds to earnings momentum; financials shine

Indian shares climbed on Monday as HDFC Bank added to last week's strong earnings releases from IT companies, countering the impact of the surge in domestic coronavirus cases past one million.

Jul 20, 2020

Life-saving Covid-19 drug remdesivir available on black market at 10 times its price

Patients' relatives are forced to pay Rs 15-60 thousand for a single vial of remdesivir on the black market that officially costs around 5 thousand in hospitals.

Jul 8, 2020

India's Hetero prices experimental COVID-19 drug remdesivir at $71 per 100 mg vial

India's Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at 5,400 rupees ($71) per 100-milligram vial, the drugmaker said on Wednesday, June 24 as it prepares to ship them to hospitals in the country.

Jun 24, 2020

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Indian drugmaker Cipla Ltd will price its generic version of Gilead Sciences Inc's antiviral drug remdesivir for use in COVID-19 patients at less than 5,000 rupees ($66), the company said.

Jun 23, 2020

Pharma powers Indian shares to three-month closing high

The NSE Nifty 50 index, which has recovered ground after taking a hit from worries about a violent border clash with China last week, ended up 0.65% at 10,311, its highest since March 11.

Jun 22, 2020

COVID-19 drug Remdesivir's price in India is a concern; Pharma cos free to set price

Gilead Sciences' signs non-exclusive license pact with four Indian drug majors to set their own price for Covid-19 drug Remdesivir. Following this move, many pharma distributors have been selling the experimental drug at Rs 7000 per vial. This will result in escalated treatment cost, to procure vials approximating to Rs 35,000 to Rs 42,000 for five doses.

Jun 5, 2020

Nifty, Sensex fall as economic package fails to impress; Reliance rises

Indian shares slipped on Monday, May 18 as investors were unimpressed by the government's economic relief measures and coronavirus cases continued to rise steadily, while a boost in Reliance Industries and Cipla limited losses.

May 18, 2020

1 2 3 4 5 6 7 8 9 10 Next